BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 3274848)

  • 1. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of some donor-recipient HLA-DR mismatches on cadaveric graft survival: proposal for a new selection policy of recipients.
    Vereerstraeten P; Andrien M; De Pauw L; Dupont E; Goldman M; Abramowicz D; Kinnaert P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):385-6. PubMed ID: 1990560
    [No Abstract]   [Full Text] [Related]  

  • 3. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
    Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D
    Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
    [No Abstract]   [Full Text] [Related]  

  • 4. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-DR1 recipients have the highest kidney transplant survival.
    Cook DJ; Cecka JM; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of cyclosporine A on the DRw6 effect in renal transplantation.
    Hendriks GF; de Lange P; Schreuder GM; D'Amaro J; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):650-1. PubMed ID: 3274832
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy.
    Taylor CJ; Bayne AM; Welsh KI; Morris PJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of donor and recipient DRw6 status on outcome of cadaver kidney transplantation.
    Vereerstraeten P; Andrien M; Dupont E; De Pauw L; Kinnaert P; Toussaint C
    Transplant Proc; 1987 Feb; 19(1 Pt 1):708-10. PubMed ID: 3547836
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E; Berthoux F; Acquart S; Lepetit JC
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical importance of HLA antigen matching in cadaveric kidney transplantation with high overall survival rates. The Manchester UK Kidney Transplant Team.
    Dyer PA; Martin S; Johnson RW
    Transplant Proc; 1992 Dec; 24(6):2454. PubMed ID: 1465827
    [No Abstract]   [Full Text] [Related]  

  • 11. DR6 compatibility and kidney graft survival.
    Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract]   [Full Text] [Related]  

  • 12. Repeated DR mismatching need not be hazardous to kidney graft survival.
    Salmela K; Eklund B; Höckerstedt K; Isoniemi H; Koskimies S; von Willebrand E; Ahonen J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):677-8. PubMed ID: 2650219
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-B, DR matching and cadaver renal allograft survival in New England. New England Organ Bank.
    Carpenter CB; Goguen JE; Bradley JW; Turka LA; Cho SI; Milford EL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):663-4. PubMed ID: 2650215
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of HLA-DR matching on rejection after cardiac transplantation.
    Cochrane A; Benson E; Williams T; Bergin P; Esmore D
    Transplant Proc; 1992 Feb; 24(1):169-70. PubMed ID: 1539227
    [No Abstract]   [Full Text] [Related]  

  • 19. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
    Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
    [No Abstract]   [Full Text] [Related]  

  • 20. Confidence levels assigned to serologic HLA-DR typing predict DNA HLA-DR typing discrepancies.
    Wetzsteon PJ; Head MA; Fletcher LA; Norman DJ
    Transplant Proc; 1992 Dec; 24(6):2483-4. PubMed ID: 1361260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.